ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 182 filers reported holding ASCENDIS PHARMA A/S in Q1 2022. The put-call ratio across all filers is 0.64 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,180,502 | -4.3% | 76,682 | -8.8% | 0.00% | 0.0% |
| Q2 2023 | $7,506,104 | -47.4% | 84,102 | -36.9% | 0.00% | -50.0% |
| Q1 2023 | $14,283,635 | +41.0% | 133,218 | +60.6% | 0.00% | +100.0% |
| Q4 2022 | $10,129,829 | -42.8% | 82,943 | -51.6% | 0.00% | -50.0% |
| Q3 2022 | $17,705,000 | -3.0% | 171,457 | -12.7% | 0.00% | 0.0% |
| Q2 2022 | $18,253,000 | +45.8% | 196,347 | +84.1% | 0.00% | 0.0% |
| Q1 2022 | $12,520,000 | +46.4% | 106,679 | +67.8% | 0.00% | +100.0% |
| Q4 2021 | $8,551,000 | -7.7% | 63,567 | +9.4% | 0.00% | 0.0% |
| Q3 2021 | $9,265,000 | -10.1% | 58,128 | -25.8% | 0.00% | 0.0% |
| Q2 2021 | $10,307,000 | +185.5% | 78,350 | +179.8% | 0.00% | 0.0% |
| Q1 2021 | $3,610,000 | -57.3% | 28,007 | -44.7% | 0.00% | 0.0% |
| Q4 2020 | $8,450,000 | +1694.1% | 50,660 | +1558.8% | 0.00% | – |
| Q3 2020 | $471,000 | +11.6% | 3,054 | +7.0% | 0.00% | – |
| Q2 2020 | $422,000 | +60.5% | 2,854 | +22.3% | 0.00% | – |
| Q1 2020 | $263,000 | -72.4% | 2,334 | -65.9% | 0.00% | – |
| Q4 2019 | $952,000 | +229.4% | 6,842 | +128.3% | 0.00% | – |
| Q3 2019 | $289,000 | +71.0% | 2,997 | +104.2% | 0.00% | – |
| Q2 2019 | $169,000 | -63.9% | 1,468 | -63.1% | 0.00% | – |
| Q1 2019 | $468,000 | -75.6% | 3,975 | -87.0% | 0.00% | -100.0% |
| Q4 2018 | $1,915,000 | -42.6% | 30,563 | -35.1% | 0.00% | 0.0% |
| Q3 2018 | $3,338,000 | +63.6% | 47,100 | +53.6% | 0.00% | 0.0% |
| Q2 2018 | $2,040,000 | +127.7% | 30,666 | +123.8% | 0.00% | – |
| Q1 2018 | $896,000 | -64.9% | 13,703 | -78.5% | 0.00% | -100.0% |
| Q4 2017 | $2,552,000 | +4.5% | 63,692 | -5.4% | 0.00% | 0.0% |
| Q3 2017 | $2,441,000 | +115.3% | 67,332 | +64.9% | 0.00% | – |
| Q2 2017 | $1,134,000 | +97.6% | 40,830 | +99.4% | 0.00% | – |
| Q1 2017 | $574,000 | +2107.7% | 20,472 | +1446.2% | 0.00% | – |
| Q4 2016 | $26,000 | -94.6% | 1,324 | -94.9% | 0.00% | – |
| Q1 2016 | $478,000 | +819.2% | 25,759 | +803.5% | 0.00% | – |
| Q4 2015 | $52,000 | +477.8% | 2,851 | +449.3% | 0.00% | – |
| Q3 2015 | $9,000 | -69.0% | 519 | -68.7% | 0.00% | – |
| Q2 2015 | $29,000 | -68.1% | 1,660 | -68.4% | 0.00% | – |
| Q1 2015 | $91,000 | – | 5,250 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 11,225,357 | $1,001,863,112 | 18.92% |
| Q Global Advisors, LLC | 195,000 | $17,404 | 12.55% |
| Sofinnova Investments, Inc. | 754,032 | $67,297,356 | 4.41% |
| Avoro Capital Advisors LLC | 3,580,555 | $319,564,534 | 4.34% |
| Finepoint Capital LP | 139,772 | $12,474,651 | 4.32% |
| Spyglass Capital Management LLC | 657,853 | $58,713,380 | 4.24% |
| Saturn V Capital Management LP | 78,442 | $7,000,948 | 3.88% |
| DAFNA Capital Management LLC | 135,212 | $12,067,671 | 3.30% |
| ARS Investment Partners, LLC | 289,860 | $25,870,005 | 3.02% |
| Ghost Tree Capital, LLC | 100,000 | $8,925,000 | 2.95% |